Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Depe… (NCT00429767) | Clinical Trial Compass
CompletedNot Applicable
Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals
United States16 participantsStarted 2007-01
Plain-language summary
The purpose of this study is to determine whether maintenance on different oral doses of sustained release d-amphetamine (SR-AMP) combined with constant-dose sublingual buprenorphine (BUP) is safe and well tolerated and decreases self-administration of cocaine alone or combined with hydromorphone (HYD). Secondary aims are to determine whether SR-AMP attenuates the subjective and physiological effects of cocaine during drug sampling periods prior to choice opportunities.
Who can participate
Age range18 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Opioid dependent and Cocaine abuse or dependence, as determined by structured clinical interview for DSM-IV (SCID) and Addiction Severity Index (ASI)
* Positive urine test for opiates and cocaine
* Willing to use an adequate form of contraception for the duration of the study
* Reads and writes English
Exclusion Criteria:
* Psychiatric illness, as determined by the DSM-IV criteria
* History of, or current neurological disease, including structural abnormalities, seizures, infectious disease, history of other neurological diseases or head trauma.
* History of cardiovascular disease, myocardial infarction, chest pain or palpations on exertion or drug use
* Systolic blood pressure greater than 160 or less than 95 mmHg; Diastolic blood pressure \>95 mmHg
* Clinically abnormal ECG
* Pulmonary disease, including asthma, obstructive pulmonary disease, cor pulmonale, tuberculosis
* Systemic disease (e.g., endocrinopathies, liver or kidney failure, myxedema, hypothyroidism, Addison's disease, autoimmune disease)
* Current alcohol or sedative drug dependence
* Pregnant or breastfeeding
* Currently receiving treatment for a Substance Abuse/Dependence Disorder or seeking treatment
* Been in a research study within the last 30 days
* Known phobia of injections